<DOC>
	<DOCNO>NCT01218802</DOCNO>
	<brief_summary>The hypothesis study 96 week Rosuvastatin safe effective decreasing cardiovascular risk bone loss HIV+ population .</brief_summary>
	<brief_title>Use Rosuvastatin HIV-Infected Subjects Modulate Cardiovascular Risks</brief_title>
	<detailed_description>While use antiretroviral therapy ( ART ) recent year impressive impact mortality disease progression HIV-infected patient , nevertheless , cardiovascular disease major concern impact morbidity mortality population . This study assess potent statin , rosuvastatin , could improve endothelial dysfunction , slow carotid intima medium thickness ( IMT ) progression bone loss , decrease inflammation oxidative stress HIV-infected ART-treated subject good HIV virologic control . The investigator also see rosuvastatin induce beneficial change prevalence metabolic syndrome lipid metabolism well improve bone turnover marker .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>Clinical diagnosis HIV Disease Age &gt; 18 year old Receiving stable ARV regimen least last 12 week prior study entry cumulative duration ARV 12 month Fasting LDL cholesterol &lt; 130 mg/dl Fasting triglycerides &lt; 300 mg/dL hsCRP &gt; 2 mg/L CD38+DR+/CD8+ &gt; 19 % If Vit D replacement therapy , stable regimen &gt; 3 month prior study entry Women pregnant breast feed Any active chronic inflammatory condition Cardiovascular disease Current recent ( within 24 week study entry ) therapy omega3 fatty acid , fibrates , ezetimibe statin Uncontrolled hypothyroidism hyperthyroidism Uncontrolled diabetes Use systemic cancer chemotherapy immunomodulating agent Use Anabolic agent , growth hormone , growth hormone release factor , anabolic agent , except stable replacement testosterone . Use biphosphonates bone therapy Any follow lab finding obtain within 14 day prior screen evaluation include follow : AST and/or ALT &gt; 2.5 x ULN Hemoglobin &lt; 9.0 g/dL CK &gt; 3 X ULN Calculated creatinine clearance &lt; 50 mL/min</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>HIV</keyword>
	<keyword>Heart Disease</keyword>
	<keyword>Bone Density</keyword>
</DOC>